The API import to Russia reached an all-time high in 2021 in both monetary and physical terms: 195.4 billion RUB (customs clearance and VAT included), or 15,800 tons. The growth rates in monetary terms (rubles) were 15.9%, the lowest in the past 5 years, and 5.4% in physical terms (tons), the lowest in the last few years as well, beside the negative -2.5% in 2018.

The vast majority of the doctors (75.3%) who took part in a survey conducted by the RNC Pharma analyst company and the platform for doctors Medvestnik believe that the abolition of internships has led to an abrupt decline in the quality of training that medical students receive.

Last year’s growth rates of the Russian pharmaceutical retail market were in line with the inflation rate. While the price index was rather impressive, in the current conditions only maintaining more or less stable figures in the market seems possible, rather than development, because in fact, the market is stagnating. Besides, even those figures were mainly the result of the growing purchasing activity in the online segment, which is still developing, primarily by luring away consumers from offline pharmacies.